Implementation of WHO-endorsed technologies for TB diagnosis in Africa: opportunities, strengths and challenges

Roll-out and scale-up of WHO-endorsed technologies for TB diagnosis in Africa: opportunities, strengths and challenges

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN24711056

Enrollment

188

Registered

2022-08-23

Start date

2022-07-20

Completion date

Unknown

Last updated

2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculosis Respiratory

Interventions

There will be a focus on the uptake, utilization, roll-out, implementation, adoption and the operationalization of WHO-TB diagnostic technologies upon endorsement by the World Health Organization foll

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Adults aged 18 years and above who occupy the position of managers of the National TB Programme, National TB Reference Laboratories and Partners

Exclusion criteria

Exclusion criteria: 1. Participants who do not consent to respond to the survey questionnaire 2. Those who are in position for less than a year

Design outcomes

Primary

Measure	Time frame
We will analyze responses by classifying countries into categories (scoring from 0 to 5). Rapid implementers will have a score of 5 if the specified technology shows its implementation occurred within 1 to 3 years after WHO endorsement, moderate implementers will be from 3 to 5 years and slow implementers will be countries that show implementation after 5 years onward following the WHO endorsement. Gaps on diagnostic part per countries will be highlighted as an impediment to notification of TB cases and enabling factors (funding, leadership,...) will be developed to better guide countries in improving their uptake. We will document threats and opportunities (from field experience) including good practices from TB laboratory services contribution to support recent emergency disease outbreaks in Africa and identify areas where integration of TB diagnostic platforms can serve other disease programmes.	—

Measure

Time frame

We will analyze responses by classifying countries into categories (scoring from 0 to 5). Rapid implementers will have a score of 5 if the specified technology shows its implementation occurred within 1 to 3 years after WHO endorsement, moderate implementers will be from 3 to 5 years and slow implementers will be countries that show implementation after 5 years onward following the WHO endorsement. Gaps on diagnostic part per countries will be highlighted as an impediment to notification of TB cases and enabling factors (funding, leadership,...) will be developed to better guide countries in improving their uptake. We will document threats and opportunities (from field experience) including good practices from TB laboratory services contribution to support recent emergency disease outbreaks in Africa and identify areas where integration of TB diagnostic platforms can serve other disease programmes.

—

Secondary

Measure	Time frame
There are no secondary outcome measures	—

Countries

Algeria, Angola, Anguilla, Burkina Faso, Burundi, Cameroon, Uganda, Zambia, Zimbabwe

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026